(Q38074337)

28 August 2017

1 reference

title

Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae (English)

1 reference

28 August 2017

0 references

0 references

1 reference

Carlos Campos

1

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

28 August 2017

published in

Postgraduate Medicine

1 reference

28 August 2017

volume

124

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

90-97

1 reference

A radical explanation for glucose-induced beta cell dysfunction

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Abnormalities in insulin secretion in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Five stages of evolving beta-cell dysfunction during progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Vascular complications in diabetes mellitus: the role of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Intensive glycemic control and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Standards of medical care in diabetes--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Mitochondrial malfunction and Ca2+ dyshomeostasis drive neuronal pathology in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Alpha-oxoaldehyde metabolism and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

The unique cytoarchitecture of human pancreatic islets has implications for islet cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Functional and molecular defects of pancreatic islets in human type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Deteriorating beta-cell function in type 2 diabetes: a long-term model

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.11.2615

21 January 2018

Identifiers

DOI

10.3810/PGM.2012.11.2615

1 reference

28 August 2017

1 reference